| abstract |
Neuropsychiatric conditions that respond to nicotine can be treated by administering a nicotine antagonist, in particular mecamylamine. The combination of a mecamilamine therapy with a neuroleptic drug is also described. Neuropsychiatric conditions include Tourette syndrome, schizophrenia, depression, bipolar disorder, tremor, attention deficit hyperactivity disorder, obsessive-compulsive disorders, hemidistonia, outbursts of anger and tardive dyskinesia. |